Clinical Trials on Severe Seborrheic Dermatitis in United Kingdom
Total 2506 results
-
Mimetica Pty LimitedCompletedSeborrhea | Oily SkinUnited States
-
Promius Pharma, LLCCompleted
-
Dermatology Specialists ResearchNovartisCompletedSeborrheic DermatitisUnited States
-
University of Alabama at BirminghamCompletedSeborrheic DermatitisUnited States
-
Icahn School of Medicine at Mount SinaiIncyte CorporationCompleted
-
University of California, DavisCompletedSeborrheic DermatitisUnited States
-
Ascension Genesys HospitalUnknownSeborrheic DermatitisUnited States
-
St. Louis UniversityCompletedSeborrheic DermatitisUnited States
-
Icahn School of Medicine at Mount SinaiPfizerRecruitingSeborrheic Dermatitis | Papulopustular RosaceaUnited States
-
Medicis Global Service CorporationCompletedSeborrheic DermatitisUnited States
-
Boston UniversityL'OrealCompleted
-
Arcutis Biotherapeutics, Inc.CompletedSeborrheic DermatitisUnited States, Canada
-
Arcutis Biotherapeutics, Inc.CompletedSeborrheic DermatitisUnited States
-
Arcutis Biotherapeutics, Inc.CompletedSeborrheic DermatitisUnited States, Canada
-
University of MinnesotaRecruitingSeborrheic Dermatitis | Dandruff | Hair LossUnited States
-
Integrative Skin Science and ResearchCodex LabsRecruitingRosacea | Seborrheic Dermatitis | Melasma | AcneUnited States
-
Aria Aesthetics Inc.CompletedRosacea | Acne Vulgaris | Seborrheic Dermatitis | Atopic DermatitisUnited States
-
Ann & Robert H Lurie Children's Hospital of ChicagoNorthwestern University Feinberg School of MedicineRecruitingDermatitis, Seborrheic | Dry Skin; EczemaUnited States
-
Royal Victoria InfirmaryBritish Skin FoundationCompletedModerate to Severe Atopic EczemaUnited Kingdom
-
Aclaris Therapeutics, Inc.CompletedSeborrheic Keratosis (SK)United States
-
University of California, DavisCompleted
-
Regeneron PharmaceuticalsSanofiCompletedModerate to Severe Atopic Hand and Foot DermatitisUnited States, Germany, Japan, Poland
-
NHS TaysideCompleted
-
Milton S. Hershey Medical CenterCompletedSeborrheic KeratosisUnited States
-
DermBiont, Inc.RecruitingA Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic KeratosisSeborrheic KeratosisUnited States
-
Aclaris Therapeutics, Inc.CompletedSeborrheic KeratosisUnited States
-
Aclaris Therapeutics, Inc.Completed
-
Aclaris Therapeutics, Inc.CompletedSeborrheic KeratosisUnited States
-
Aclaris Therapeutics, Inc.CompletedSeborrheic KeratosisUnited States
-
University of Texas Southwestern Medical CenterChildren's Medical Center DallasTerminatedModerate to Severe Atopic DermatitisUnited States
-
Pulse Biosciences, Inc.CompletedSeborrheic Keratosis | Lesion SkinUnited States
-
Imperial College LondonJP Moulton Charitable FoundationRecruitingAtopic Dermatitis EczemaUnited Kingdom
-
Aclaris Therapeutics, Inc.CompletedSeborrheic KeratosisUnited States
-
Momentum DataPfizer; Royal College of General Practitioners Research and Surveillance CentreUnknownEczema | Atopic Dermatitis | Atopic Dermatitis EczemaUnited Kingdom
-
Aclaris Therapeutics, Inc.CompletedSeborrheic KeratosisUnited States
-
Aclaris Therapeutics, Inc.Completed
-
DermBiont, Inc.RecruitingNon-Melanoma Skin CancersUnited States
-
Qurient Co., Ltd.CompletedModerate to Severe Atopic DermatitisUnited States
-
Galderma R&DCompletedModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Canada, Czechia, Germany, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Spain, United Kingdom
-
Regeneron PharmaceuticalsSanofiCompletedModerate-to-severe Atopic DermatitisUnited States
-
Inmagene LLCActive, not recruitingAtopic Dermatitis | Moderate-to-severe Atopic Dermatitis | ADCanada, United States
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of Sheffield; Sheffield Children's NHS Foundation TrustCompleted
-
Atopix Therapeutics, Ltd.Completed
-
Galderma R&DRecruitingModerate-to-Severe Atopic DermatitisUnited States, Denmark, Hungary, Poland, Spain
-
LEO PharmaCompletedAtopic DermatitisUnited Kingdom
-
University College, LondonDermatrustWithdrawn
-
Galderma R&DActive, not recruitingModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Singapore, Spain, United Kingdom
-
Sanofi Pasteur, a Sanofi CompanyUnited States Department of DefenseCompletedDengue | Dengue Fever | Dengue Hemorrhagic FeverUnited States
-
BenevolentAI BioCompletedAtopic DermatitisUnited Kingdom
-
Wake Forest UniversityCompletedHand DermatosisUnited States